EUVIMEDEUVIMED entdecken
Crossref

Differences between HbA1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia – The PREVIEW trial

Marta P Silvestre, Mikael Fogelholm, Marta Alves, Ana Papoila, Tanja Adam, Amy Liu, Jennie Brand-Miller, J Alfredo Martinez, Margriet Westerterp-Plantenga, Teodora Handjieva-Darlenska, Ian A Macdonald, Ruixin Zhu und 7 weitere

Clinical Nutrition · 2023

DOI: 10.1016/j.clnu.2023.02.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2023. Verfasst von Marta P Silvestre und 18 weiteren Autor:innen. Beteiligte Einrichtung: Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand; CINTESIS, NOVA Medical Sc…. Hauptthemen laut MEDLINE: Hyperglycemia, Prediabetic State, Glucose Intolerance, Insulins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: To examine the differences between HbA1c and glucose related variables in predicting weight loss and glycaemic changes following 8 weeks of low energy diet (LED) in individuals with overweight and hyperglycaemia. RESEARCH DESIGN AND METHODS: 2178 individuals with ADA-defined pre-diabetes - impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) - who started an 8 week LED weight loss diet, were included in this analysis. Participants were enrolled in the PREVIEW (PREVention of diabetes through lifestyle interventions and population studies In Europe and around the World) clinical trial. Multivariable linear mixed effects regression models and generalised additive mixed effect logistic models were used. RESULTS: Only 1 in 3 participants (33%) had HbA1c levels defined as pre-diabetes. Neither baseline HbA1c, IFG or IGT were associated with body weight change at 8 weeks. Higher baseline body weight, baseline fasting insulin and weight loss predicted normalisation of fasting plasma glucose (FPG), whilst higher baseline fasting insulin, C-reactive protein (hsCRP) and older age predicted normalisation of HbA1c. Additionally, male sex and higher baseline BMI, body fat and energy intake were positively associated with weight loss, whereas greater age and higher HDL-cholesterol predicted less weight loss. CONCLUSIONS: Whilst neither HbA1c nor fasting glucose predicts short-term weight loss success, both may impact the metabolic response to rapid weight loss. We propose a role of inflammation versus total body adiposity since these variables are independent predictors of the normalisation of HbA1c and fasting glucose, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaPrediabetic StateGlucose IntoleranceInsulinsDiabetes Mellitus, Type 2MaleHumansGlucoseBlood GlucoseOverweightFastingC-Reactive ProteinWeight Loss

Stichwörter der Autor:innen

Hemoglobin A(1c)Impaired fasting glucoseImpaired glucose tolerancePrediabetesWeight loss/ reduction

Substanzen

GlucoseBlood GlucoseC-Reactive ProteinInsulins

Autor:innen und Institutionen

  • Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand; CINTESIS, NOVA Medical School, NMS, Universidade Nova de Lisboa, 1169-056, Lisboa, Portugal. El…
  • Department of Food and Nutrition, University of Helsinki, Helsinki, Finland.
  • CEAUL, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056, Lisboa, Portugal.
  • Department of Nutrition and Movement Sciences, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
  • Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand.
  • School of Life and Environmental Sciences and Charles Perkins Centre, University of Sydney, Sydney, Australia.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

P Silvestre, M., Fogelholm, M., Alves, M., Papoila, A., Adam, T., Liu, A., Brand-Miller, J., Martinez, J. A., Westerterp-Plantenga, M., Handjieva-Darlenska, T., Macdonald, I. A., Zhu, R., Jalo, E., Muirhead, R., Carretero, S. N., Handjiev, S., Taylor, M. A., Raben, A., & Poppitt, S. D. (2023). Differences between HbA1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia – The PREVIEW trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.02.023

Vancouver

P Silvestre M, Fogelholm M, Alves M, Papoila A, Adam T, Liu A, et al. Differences between HbA1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia – The PREVIEW trial. Clinical Nutrition. 2023. doi:10.1016/j.clnu.2023.02.023

BibTeX
@article{PSilvestre2023,
  author = {P Silvestre, Marta and Fogelholm, Mikael and Alves, Marta and Papoila, Ana and Adam, Tanja and Liu, Amy and Brand-Miller, Jennie and Martinez, J Alfredo and Westerterp-Plantenga, Margriet and Handjieva-Darlenska, Teodora and Macdonald, Ian A and Zhu, Ruixin and Jalo, Elli and Muirhead, Roslyn and Carretero, Santiago Navas and Handjiev, Svetoslav and Taylor, Moira A and Raben, Anne and Poppitt, Sally D},
  title = {Differences between HbA1c and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia – The PREVIEW trial},
  journal = {Clinical Nutrition},
  year = {2023},
  doi = {10.1016/j.clnu.2023.02.023}
}
Kostenlos starten →